[HTML][HTML] Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators
L Gonzalez-Fajardo, OL Fernández… - PLoS Neglected …, 2015 - journals.plos.org
Background Therapeutic response in infectious disease involves host as well as microbial
determinants. Because the immune and inflammatory response to Leishmania (Viannia) …
determinants. Because the immune and inflammatory response to Leishmania (Viannia) …
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
P Di Sciullo, F Menay, F Cocozza, MJ Gravisaco… - Clinical …, 2019 - Elsevier
T-cell lymphomas include diverse malignancies. They are rare, some have low survival rates
and they lack curative therapies. The aim of this work was to assess whether employing the …
and they lack curative therapies. The aim of this work was to assess whether employing the …
Proteomic analysis of stratum corneum in Cutaneous T‐Cell Lymphomas and psoriasis
B Méhul, C Ménigot, P Fogel… - Experimental …, 2019 - Wiley Online Library
Stratum corneum collected by tape stripping from 10 and 24 subjects with cutaneous T‐cell
lymphomas (CTCL) or psoriasis, respectively, were compared using quantitative label‐free …
lymphomas (CTCL) or psoriasis, respectively, were compared using quantitative label‐free …